Controversy

Can conventional + advanced MRI reliably separate intramedullary neoplasm from non-neoplastic myelopathy?

Evidence grade: WEAK — Supported only by weak or preliminary evidence.

computed from the encoded evidence by the Atlas grading rule.

Position A

DTI/tractography and enhancement/morphology patterns differentiate tumor from inflammatory/compressive myelopathy

Position B

Spondylotic and inflammatory myelopathy routinely mimic intramedullary tumor; biopsy is still often required

Clinical stakes

A wrong call sends a patient to cord biopsy/resection or to immunotherapy; stakes are very high with genuine overlap.

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Reviewed by Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Last updated 2026-07-14.

This is an educational research resource from Resonant Labs, not clinical advice. Evidence grades and controversies are summarized from the literature and may change as the field evolves.